Interim Results

CHAIRMAN'S STATEMENT for the six months ended 30 September 2007 Financial Highlights - Group turnover (consolidated) for the period is £2.518m compared with £2.10060m for the same period last year, representing an increase of 22%. - Group profit before tax provision is £364,000, a 49% increase in the figure of £244,000 for the same period last year. - Diluted earnings per share at the interim stage in respect of continuing activities are 2.14p representing a 22% rise above the 1.76p achieved in the corresponding period last year. - Net cash inflow from operating activities was £479,000 (£87,000 in the same period last year). After payment of dividends (£93,000), repayment of borrowings (£140,000) and final payments relating to previous acquisitions (£159,000), there was a £78,000 net increase in cash. This resulted in cash reserves rising to £1.547m at the end of the period. The pattern of work continues to result in an interchange of work between subsidiaries. There is a core of personnel in the Group with the skills to undertake assignments on behalf of any trading subsidiary. Subsequently, the contracts earned by one subsidiary may be carried out and invoiced by another member of the Group and we have a policy of not cross-charging between subsidiaries. In consequence the individual performance of each subsidiary may be distorted and thus the consolidated Group position is the only true measure of performance. Corporate Review Acquisitions There have been no acquisitions in the period although, as previously announced, Heads of Terms have been signed with two companies as detailed below. Heads of Terms have been agreed with In House The Hygiene Management Company (IH), a food hygiene practice. Due diligence is underway and completion is expected before the end of the calendar year. Turnover for IH in the six months to 30 June 2007 was £197,000, generating pre-tax profits of £56,000 (unaudited). IH will enter into a strategic partnership with our RSA Environmental Health subsidiary, and will be managed from RSA's Midlands offices. The initial consideration for IH is agreed at £200,000 with further payments each of £50,000 on the first and second anniversaries. Each anniversary payment is subject to a self-funded bonus according to profits. Heads of Terms have been agreed with Guardian Water Treatment Limited (Guardian), a company specialising in air and water quality management. Due diligence is underway and completion is expected before the end of the calendar year, but after the IH acquisition. Guardian's turnover in the year to 31 March 2007 was £2.1m, generating pre-tax profits of £263,000 (unaudited). Management accounts indicate that Guardian is currently trading ahead of last year's performance. The maximum purchase price is £2.15m (including the freehold property based on current property values) and comprises payment on completion of £900,000, a further unconditional payment of £400,000 on the first anniversary of completion and a bonus payment on the second anniversary of completion of £200,000 on the basis that the adjusted earnings before interest and tax (EBIT) for the trading year to 31 March 2009 reaches a minimum of £400,000. This payment will be adjusted pound for pound by the amount that EBIT is above or below that figure, subject to a minimum payment of £50,000 and a maximum of £400,000. The Group will purchase the business property at fair market value within an agreed period after completion. This property is currently valued at £450,000. Performance by Trading Subsidiaries Profit figures for individual subsidiaries are stated before tax and management charges. Adamson's Laboratory Services Limited Invoiced sales of £1,407,319, yielding a profit of £277,838 (the figures for the same period last year were £1,099,216 and £190,069). Envex Company Limited Invoiced sales of £123,818, resulting in a loss of £6,874 for the period. There are no comparable figures for last year as the company was not part of the Group at that time. Personnel Health and Safety Consultants Limited Invoiced sales of £508,377, yielding a profit of £255,637 (the figures for the same period last year were £514,295 and £210,602). RSA Environmental Health Limited Invoiced sales of £479,266, yielding a profit of £29,091 (the figures for the same period last year were £445,866 and £29,526). Dividend The Board is not recommending payment of an interim dividend, but expects to propose an appropriate final dividend at the end of the year. Prospects It has traditionally been the case that demand for the Group's services is higher in the second half of the year. Despite the excellent first half performance, we believe that this trend will continue in the current financial year. Subject to completing both acquisitions as anticipated, there will also be significant new revenues and profits to supplement those generated by continuing operations. Stephen King - Chairman and Managing Director Consolidated income statement Six months Six months Year ended ended ended 30 Sept 07 30 Sept 06 31 Mar 07 Note Unaudited Restated Restated £'000 £'000 £'000 Revenue 2,518 2,060 4,589 Cost of sales 1,374 1,081 2,306 Gross profit 1,144 979 2,283 Other operating income 1 1 2 Administrative expenses (792) (728) (1,506) Profit from operations 353 252 779 Finance revenue 22 5 10 Finance costs (11) (13) (29) Profit before tax 364 244 760 Taxes (111) (68) (239) Profit for the period from continuing operations 253 176 521 Loss for the period from discontinued operations - (26) (59) Attributable to: Equity holders of the Group 253 150 462 Earnings per share 3 Continuing operations 2.17p 1.79p 5.30p Discontinued operations - (0.26)p (0.60)p Diluted earnings per share Continuing operations 2.14p 1.76p 5.21p Discontined operations - (0.26)p (0.59)p Consolidated balance sheet 30 Sept 07 30 Sept 06 31 Mar 07 Unaudited Restated Restated Note £'000 £'000 £'000 Non-current assets Property, plant and equipment 2 823 700 818 Intangible assets 47 81 49 Goodwill 2,206 2,192 2,191 3,076 2,973 3,058 Current assets Inventories 316 376 389 Trade and other receivables 821 786 951 Cash and cash equivalents 1,547 319 1,469 2,684 1,481 2,809 Current liabilities Trade and other payables 410 487 648 Current tax payable 347 250 236 Borrowings 83 73 84 840 810 968 Net current assets 1,844 671 1,841 Total assets less current liabilities 4,920 3,644 4,899 Non-current liabilities Long-term borrowings 148 270 287 Deferred taxation 91 91 91 239 361 378 4,681 3,283 4,521 Equity Share capital and premium 2,629 1,703 2,629 Other reserves 208 205 208 Retained earnings 1,844 1,375 1,684 Total equity 4,681 3,283 4,521 Consolidated Statement of Changes in Equity Other Reserves Capital Share Share Redemption Revaluation Retained Total Capital Premium Reserve Resereve Earnings Equity £'000 £'000 £'000 £'000 £'000 £'000 Balance at 1 April 2006 983 728 - 205 1,298 3,214 Profit attributable to equity holders - - - - 150 150 vidends - - - - (73) (73) Purchase of own shares (2) (6) - - - (73) Balance at 30 September 2006 981 722 0 205 1,375 3,283 Balance at 1 April 2007 1,166 1,463 6 202 1,684 4,521 Profit attributable to equity holders - - - - 253 253 Dividends - - - - (93) (93) Balance at 30 September 2007 1,166 1,463 6 202 1,844 4,681 Consolidated cash flow statement Six months Six months Year ended ended ended 30 Sept 07 30 Sept 06 31 Mar 07 Unaudited Restated Restated £'000 £'000 £'000 Cash flows from operating activities Cash generated from operations 490 102 661 Interest paid (11) (15) (32) Tax paid - - (186) Net cash generated from operating activities 479 87 443 Cash flows from investing activities Purchase of property, plant and equipment (31) (10) (167) Disposal of property, plant and equipment - 3 7 Purchase of subsidiary companies (159) (133) (159) Interest received 22 5 10 Net cash used in investing activities (168) (135) (309) Cash flows from financing activities Proceeds from borrowings - - 95 Repayments of borrowings (140) (48) (92) Dividends paid to group shareholders (93) (64) (73) Proceeds from share issues - (8) 918 Net cash (used in) / from financing activities (233) (120) 848 Net increase/(decrease) in cash and cash equivalents 78 (168) 982 Cash and cash equivalents at beginning of year 1,469 487 487 Cash and cash equivalents at end of year 1,547 319 1,469 Notes to the cash flow statement Cash generated from operations Profit before tax 364 218 735 Finance revenue (22) (5) (10) Finance cost 11 13 32 Depreciation 29 42 81 (Increase)/decrease in inventories 73 (80) (83) Decrease/(increase) in trade and other receivables 129 (97) (251) (Decrease)/increase in trade and other payables (94) 8 154 Loss on disposal of financial assets - 3 3 Cash generated from operations 490 102 661 Notes on the financial statements 1. The unaudited financial information comprises the consolidated interim balance sheets as at 30 September 2007 and 30 September 2006 and the related consolidated interim statements of income, changes in equity and cash flows and related notes for the six months then ended (hereinafter referred to as the "financial information"). The financial information, including the comparative figures for the year ended 31 March 2007, do not constitute statutory financial statements for the purposes of Section 240 of the Companies Act 1985. A copy of the statutory financial statements for the year ended 31 March 2007, prepared under UK Generally Accepted Accounting Principles ("UK GAAP"), has been delivered to the Registrar of Companies and contained an unqualified auditors' report in accordance with Section 235 of the Companies Act 1985. PHSC plc has adopted International Financial Reporting Standards ("IFRS") with effect from 1 April 2007, in accordance with European Union Regulations and the London Stock Exchange AIM Rules. The first Annual Report prepared under IFRS will be for the year ended 31 March 2008. In compliance with IFRS 1 'First Time Adoption of International Financial Reporting Standards', the date of transition to IFRS is 1 April 2006. The interim financial information has been prepared in accordance with the recognition and measurement requirements of IFRS as endorsed by the European Union. The Directors do not consider that there are any significant changes to the Group's accounting policies (as set out in the 2007 Annual Report) other than those resulting from the adoption of IFRS. An explanation of how transition to IFRS has affected the reported financial position and performance of the Group is provided below. 30 Sept 07 30 Sept 06 31 Mar 07 Unaudited Restated Restated 2 Property, plant and equipment £'000 £'000 £'000 Cost or valuation Brought forward 1,008 875 875 Additions 31 11 167 Disposals - (14) (25) Acquisition of subsidiary - - 3 Disposal of subsidiary - - (11) 1,039 872 1,009 Depreciation Brought forward 191 156 156 Charge 25 23 53 Eliminated on disposal - (7) (18) 216 172 191 Net book value 823 700 818 3 Earnings per share The calculation of the basic and diluted earnings per share is based on the following data: Earnings 30 Sept 07 30 Sept 06 31 Mar 07 £'000 £'000 £'000 Continuing activities 253 176 521 Discontinued activities - (26) (59) Number of shares 30 Sept 07 30 Sept 06 31 Mar 07 Weighted average number of shares for the purpose of basic earnings per share 11,657,296 9,824,684 9,838,547 Effect of dilutive warrants 163,373 163,373 163,373 Weighted average number of shares for the purpose of diluted earnings per share 11,820,669 9,988,057 10,001,920 Reconciliation of figures reported under UK GAAP to IFRS RECONCILIATION OF PROFIT FOR THE HALF YEAR ENDED 30 SEPTEMBER 2006 Presentational effects of Adjustments on Note UK GAAP transition to transition to IFRS IFRS IFRS (Note 3) Revenue 2,103 (43) 2,060 Cost of sales (1,085) 4 (1,081) Gross profit 1,018 (39) 979 Other operating income 1 1 I Administrative expenses (841) 63 50 (728) Profit from operations 178 24 50 252 Finance revenue 5 5 Finance costs (15) 2 (13) Profit before tax 168 26 50 244 Taxes (68) (68) Profit for the period from continuing operations 100 26 50 176 Profit for the period from discontinued operations - (26) (26) 100 0 50 150 RECONCILIATION OF PROFIT FOR THE YEAR ENDED 31 MARCH 2007 Presentational effects of Adjustments on transition to transition to Note UK GAAP IFRS IFRS IFRS (Note 3) Revenue 4,649 (60) 4,589 Cost of sales (2,312) 6 (2,306) Gross profit 2,337 (54) 2,283 Other operating income 2 2 I Administrative expenses (1,683) 76 101 (1,506) Profit from operations 656 22 101 779 Finance revenue 10 10 Finance costs (32) 3 (29) Profit before tax 634 25 101 760 Loss on sale discontinued operations (34) 34 0 Taxes (239) (239) Profit for the period from continuing operations 361 59 101 521 Profit for the period from discontinued operations (59) (59) 361 0 101 462 RECONCILIATION OF SHAREHOLDER'S EQUITY AT 1 APRIL 2006 Adjustments on transition to Note UK GAAP IFRS IFRS Property plant and equipment 719 719 Intangible assets 2,280 2,280 Total non-current assets 2,999 2,999 Inventories 297 297 Trade and other receivables 689 689 Cash and cash equivalents 487 487 Total current assets 1,473 1,473 Trade and other payables (493) (493) Current tax payable (182) (182) Borrowings (74) (74) Current liabilities (749) (749) Long term borrowings (417) (417) II Deferred taxation (13) (78) (91) Non-current liabilities (430) (508) 3,293 3,215 Share capital 1,711 1,711 Fair value and other reserves 206 206 II Retained earnings 1,376 (78) 1,298 3,293 3,215 RECONCILIATION OF SHAREHOLDER'S EQUITY AT 30 SEPTEMBER 2006 Adjustments on transition to Note UK GAAP IFRS IFRS Property plant and equipment 700 700 I Intangible assets 81 81 Goodwill 2,142 50 2,192 Total non-current assets 2,923 2,973 Inventories 376 376 Trade and other receivables 786 786 Cash and cash equivalents 319 319 Total current assets 1,481 1,481 Trade and other payables (487) (487) Current tax payable (250) (250) Borrowings (73) (73) Current liabilities (810) (810) Long term borrowings (270) (270) II Deferred taxation (13) (78) (91) Non-current liabilities (283) (361) 3,311 3,283 Share capital 1,703 1,703 Fair value and other reserves 205 205 I&II Retained earnings 1,403 (28) 1,375 3,311 3,283 RECONCILIATION OF SHAREHOLDER'S EQUITY AT 31 MARCH 2007 Adjustments on transition to Note UK GAAP IFRS IFRS Property plant and equipment 818 818 I Intangible assets 49 49 Goodwill 2,090 101 2,191 Total non-current assets 2,957 3,058 Inventories 389 389 Trade and other receivables 951 951 Cash and cash equivalents 1,469 1,469 Total current assets 2,809 2,809 Trade and other payables (648) (648) Current tax payable (236) (236) Borrowings (84) (84) Current liabilities (968) (968) Long term borrowings (287) (287) II Deferred taxation (13) (78) (91) Non-current liabilities (300) (378) 4,498 4,521 Share capital 2,629 2,629 Fair value and other reserves 208 208 I&II Retained earnings 1,661 23 1,684 4,498 4,521 PRINCIPAL DIFFERENCES BETWEEN UK GAAP AND IFRS The principal differences which give rise to changes in the Group's reported profit for the year ended 31 March 2007 and half year ended 30 September 2006 and net assets at 1 April 2006, 30 September 2006 and 31 March 2007 are as follows. I Amortisation of goodwill on consolidation The Group has availed of the exemption in IFRS1 not to apply IFRS 3 'Business Combinations' retrospectively to business combinations that took place prior to 1 April 2006. Goodwill has been tested for impairment at the transition date and at each period end date. Amortisation charged since the transition date has been reversed as follows: Period ended 30 September 2006 £50,000 Year ended 31 March 2007 £101,000 II Deferred tax In accordance with IAS 12 'Income Taxes' a deferred tax liability has been recognised on the revaluation of the Group's properties, which took place prior to the date of transition. The deferred tax liability has been recognised in the Group's revaluation reserve. A provision for deferred tax of £78,000 has been recognised in respect of the revalued properties. III Presentational adjustment The amounts in respect of the Group's discontinued operations have been restated to reflect the requirements of IFRS 5 'Non-current Assets Held for Sale and Discontinued Operations'. For further information contact: PHSC plc Stephen King 01622 717700 stephen.king@phsc.co.uk www.phsc.plc.co.uk Ruegg & Co Limited Gavin Burnell / Brett Miller 020 7584 3663 gburnell@ruegg.co.uk Hichens, Harrison & Co plc Daniel Briggs 020 7382 7776 PHSC plc

Companies

PHSC (PHSC)
UK 100

Latest directors dealings